Hubei Haosun Pharmaceutical Co., Ltd.(HAOSUN) was founded in January 2003, with official address of No.20 Juxian Road,Gedian Economic & Technology Development Area,Hubei —the Valley of Medicine in China. It's a joint venture enterprise which integrates the research, development, production and sales of western medicine, cosmetics, health food, pharmaceutical raw materials and pharmaceutical intermediates. Total area is 66667m2,and it has more than 150 staffs.
Haosun has been conducting the development, manufacture and management according to the cGMP requirements and performing the system certification of ISO9001, ISO14001 and OHSAS18001. Haosun was approved by FDA for Flumazenil and granisetron hydrochloride in May 2007. Haosun got CEP for Flumazenil in February 2010, and for Glimepiride,Granisetron Hydrochloride & amisulpride in 2011. Seven products passed the Mexican GMP inspection in Apr. 2010. Haosun passed MHRA and FDA joint inspection the KFDA inspection in 2011. In Oct. 2011, Haosun got the GMP certificate of MHRA.
Haosun adheres to make great products, do conscience products and sere the society as the philosophy, sticks to be high tech, high quality, low cost, broad spreading and international development strategy. It will carry the beauty industry for ever and benefits human-beings.
